From: Unfavourable risk factor control after coronary events in routine clinical practice
Mean age at index event (Standard Deviation) | 61.6 (9.6) |
Women (%) | 21 |
Smoking (%) | 35 |
Diagnoses | |
ST-elevation infarction (%) | 30 |
Non ST-elevation infarction (%) | 50 |
Stable or unstable angina (%) | 20 |
More than 1 coronary event (%) | 30 |
Angiographic findings | |
No significant stenoses (%) | 6 |
Singel vessel disease (%) | 55 |
Multi-vessels disease (%) | 39 |
Intervention | |
PCIa with stent (%) | 75 |
PCIa without stent (%) | 2 |
Coronary artery bypass graft operation (%) | 13 |
No intervention (%) | 10 |
Previous or ongoing participation in cardiac rehabilitation (%) | 50 |
Co-morbidity | |
Hypertension (%) | 43 |
Diabetes type I or II (%) | 17 |
Heart failure (%) | 13 |
Atrial fibrillation (%) | 9 |
Stroke or transitory ischemic attack (%) | 7 |
Peripheral artery disease (%) | 9 |
Medication at discharge after the index event | |
Aspirin (%) | 99 |
Other antiplateles (%) | 88 |
Statins (%) | 96 |
Beta blockers (%) | 85 |
ACE inhibitors or ARBb (%) | 56 |
Calsium channel blockers (%) | 16 |
Diuretics (%) | 22 |
Antidiabetic (%) | 11 |
Insulin (%) | 4 |
Wafarin or NOACc (%) | 7 |